Emergency Zika Vaccine Could be Ready by October
A vaccine for the Zika virus, being developed by a consortium, including Inovio Pharmaceuticals, Inc. (NASDAQ: INO), could be ready for emergency use by October, according to a report by Reuters on Thursday. The vaccine is being developed by U.S. and Canadian scientists and could be ready for human trials by September, subject to regulatory approval.
A collaboration on development of a Zika virus vaccine between Inovio and Korea's GeneOne Life Science was announced on January 22.
Inovio closed Thursday at $5.78, up $0.41.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.